Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
157 studies found for:    HEPATITIS B VACCINE, RESPONSE TO
Show Display Options
Rank Status Study
1 Completed Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator
Condition: Hepatitis B
Intervention: Biological: Resiquimod gel
2 Active, not recruiting A Trial Investigating the Influence of BCG and Hepatitis B Immunisation at Birth on Neonatal Immune Responses: The Early Life Vaccines and Immunity Study
Condition: Innate Immune Response
Interventions: Drug: BCG Vaccine;   Drug: Hepatitis B Vaccine
3 Completed
Has Results
The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B Vaccines
Condition: Hepatitis B
Intervention: Biological: hepatitis B vaccine
4 Completed Dose of Hepatitis B Vaccines in Non/Low-response Populations
Condition: Vaccination; Complications, Reaction, Serum
Intervention: Biological: hepatitis B vaccine
5 Completed
Has Results
Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children
Condition: Hepatitis B
Intervention: Biological: Engerix-B™ Kinder
6 Completed
Has Results
Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.
Condition: Hepatitis B
Intervention: Biological: Engerix™-B
7 Completed The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults
Condition: Hepatitis B
Interventions: Drug: Alendronate;   Drug: Hepatitis B Vaccine;   Drug: Placebo
8 Completed A Study to Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B Vaccines
Condition: Hepatitis B
Interventions: Biological: Engerix B IM injection - 20ug;   Biological: Fendrix IM injection - 20ug
9 Completed Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge
Condition: Hepatitis B
Intervention: Biological: Engerix™-B Kinder
10 Completed A Study of the Immune Response to Heplisav in Healthy Older Adults
Condition: Hepatitis B
Intervention: Biological: HEPLISAV
11 Unknown  Immune Response to HBV Booster Vaccination After 20-23 Years
Condition: Hepatitis B Vaccination
Intervention: Biological: HBV booster vaccination 1dose
12 Completed Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth
Condition: Diphtheria; Haemophilus Influenzae Type b; Hepatitis B; Tetanus; Whole Cell Pertussis
Intervention: Biological: DTPw-HBV/Hib-MenAC conjugate vaccine
13 Unknown  Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy
Condition: Hepatitis B
Interventions: Drug: Entecavir;   Drug: Entecavir, Adefovir
14 Active, not recruiting Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4- to 5 Year Old Children Previously Vaccinated With VAXELIS or INFANRIX Hexa
Conditions: Hepatitis B;   Pertussis
Intervention: Other: Blood Sample
15 Completed Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib
Condition: Hepatitis B
Intervention: Biological: hepatitis B vaccine
16 Completed Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib
Condition: Hepatitis B
Intervention: Biological: hepatitis B vaccine
17 Completed
Has Results
Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine.
Condition: Hepatitis B
Intervention: Biological: EngerixTM-B
18 Unknown  Antigen-specific Immune Response to Hepatitis B Virus in Utero
Condition: Hepatitis B
Intervention:
19 Completed Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Alfa-2b Treatment to Increase Sustained Response in HBeAg-positive Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: PegIFN alfa-2b
20 Completed A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXA
Condition: Hepatitis B
Interventions: Biological: HBVaxPRO® 5 µg / 0.5 mL;   Biological: Engerix B® 10 µg / 0.5 mL

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.